InMode Ltd. Stock

Equities

INMD

IL0011595993

Advanced Medical Equipment & Technology

Market Closed - Nasdaq 04:00:00 2024-04-26 pm EDT 5-day change 1st Jan Change
17.14 USD +0.71% Intraday chart for InMode Ltd. -1.55% -22.93%
Sales 2024 * 492M Sales 2025 * 534M Capitalization 1.44B
Net income 2024 * 199M Net income 2025 * 216M EV / Sales 2024 * 0.87 x
Net cash position 2024 * 1.01B Net cash position 2025 * 1.27B EV / Sales 2025 * 0.31 x
P/E ratio 2024 *
7.37 x
P/E ratio 2025 *
6.83 x
Employees 581
Yield 2024 *
-
Yield 2025 *
-
Free-Float 88.25%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.71%
1 week-1.55%
Current month-20.68%
1 month-17.08%
3 months-26.28%
6 months-10.96%
Current year-22.93%
More quotes
1 week
16.82
Extreme 16.82
17.80
1 month
16.82
Extreme 16.82
21.92
Current year
16.82
Extreme 16.82
26.80
1 year
16.82
Extreme 16.82
48.25
3 years
16.82
Extreme 16.82
99.27
5 years
6.53
Extreme 6.53
99.27
10 years
6.53
Extreme 6.53
99.27
More quotes
Managers TitleAgeSince
Founder 57 08-01-01
Chief Executive Officer 71 08-01-01
Director of Finance/CFO 46 16-12-31
Members of the board TitleAgeSince
Director/Board Member 89 19-08-06
Chief Executive Officer 71 08-01-01
Founder 57 08-01-01
More insiders
Date Price Change Volume
24-04-26 17.14 +0.71% 969,384
24-04-25 17.02 -1.96% 1,032,440
24-04-24 17.36 -0.06% 924,945
24-04-23 17.37 +1.34% 923,636
24-04-22 17.14 -1.55% 1,218,459

Delayed Quote Nasdaq, April 26, 2024 at 04:00 pm EDT

More quotes
Inmode Ltd is an Israel-based global provider of energy-based, minimally-invasive surgical medical treatment solutions. Company's products and solutions are primarily designed to address three energy-based treatment categories comprised of: face and body contouring; medical aesthetics; and women’s health. The Company have developed and commercialized products utilizing medically-accepted RF energy technology, which can penetrate deep into the subdermal fat, allowing adipose tissue remodeling. It's RF energy-based proprietary technologies - Radio Frequency Assisted Lipolysis (RFAL), Deep Subdermal Fractional RF, Simultaneous Fat Destruction and Skin Tightening and Deep Heating Collagen Remodeling for skin and human natural openings- represent a paradigm shift in the minimally-invasive aesthetic solutions market. These technologies are used by physicians to remodel subdermal adipose, or fatty tissue in a variety of procedures.
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
17.02 USD
Average target price
27.6 USD
Spread / Average Target
+62.16%
Consensus